Show simple item record

dc.contributor.authorErdogan, N
dc.contributor.authorYilmaz, H
dc.contributor.authorPaker, N
dc.contributor.authorGulsen, G
dc.contributor.authorBicki, D
dc.contributor.authorKesiktas, N
dc.date.accessioned2021-03-03T09:57:36Z
dc.date.available2021-03-03T09:57:36Z
dc.date.issued2004
dc.identifier.citationKesiktas N., Paker N., Erdogan N., Gulsen G., Bicki D., Yilmaz H., "The use of hydrotherapy for the management of spasticity", NEUROREHABILITATION AND NEURAL REPAIR, cilt.18, sa.4, ss.268-273, 2004
dc.identifier.issn1545-9683
dc.identifier.otherav_1fd83180-4b82-4613-ab56-944ed497ab96
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26507
dc.identifier.urihttps://doi.org/10.1177/1545968304270002
dc.description.abstractIntroduction. Spasticity is a major problem for the rehabilitation team. Physiotherapy is a vital component of therapy. Oral medication and other modalities such as beat, cold, ultrasound, electrical stimulation, and surgery (neurosurgical or orthopedic) can also be used. The aim of this study was to compare the effects of hydrotherapy on spasticity and Functional Independence Measure (FIM) scores of patients with spinal cord injury (SCI). Materials and Methods. This is a control case matched study. Twenty SCI patients were divided into 2 groups and matched for age, gender, injury time, Ashworth scores, oral baclofen intake, American Spinal Injury Association, and FIM scores. The control group received passive range of motion exercise twice a day and oral baclofen for 10 weeks. The study group also received passive range of motion and oral baclofen, as well as 20 min of water exercises (at 71degreesF full immersion) 3 times per week. The authors evaluated spasm severity, FIM scores, oral baclofen intake, and Ashworth scales, between groups at the beginning and at the end of the treatment Period. Results. Both groups demonstrated a significant increase in FIM scores. However, the hydrotherapy group demonstrated a larger increase (P < 0.0001) than the control group. There was a statistically significant decrease in oral baclofen intake in the hydrotherapy group (P < 0.01). There was no statistical change in the control group. Spasticity was evaluated by the Ashworth scale. There was a statistical improvement in each group (P < 0.01 P < 0.02). However, when compared to the control group, the use of hydrotherapy produced a significant decrease in spasm severity (P < 0.02). Conclusion. Side effects are often seen when using oral drug treatment for spasticity. Adding hydrotherapy to the rehabilitation program can be helpful in decreasing the amount of medication required. Future studies must evaluate benefits of hydrotherapy for rehabilitation.
dc.language.isoeng
dc.subjectNöroloji
dc.subjectTıp
dc.subjectFiziksel Tıp ve Rehabilitasyon
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectREHABİLİTASYON
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleThe use of hydrotherapy for the management of spasticity
dc.typeMakale
dc.relation.journalNEUROREHABILITATION AND NEURAL REPAIR
dc.contributor.department, ,
dc.identifier.volume18
dc.identifier.issue4
dc.identifier.startpage268
dc.identifier.endpage273
dc.contributor.firstauthorID173481


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record